Case 6. Basic clinical data Archive case of I. Alvarado-Cabrero (Centro Medico, Mexico City) Archive case of I. Alvarado-Cabrero (Centro Medico, Mexico.

Slides:



Advertisements
Similar presentations
Case 20 Thomas J. Giordano, M.D., Ph.D.. History A 54-year old man with a past medical history of goiter for approximately 4 years was followed by ultrasound.
Advertisements

1 Renal Pelvis, Ureter, Bladder and Other Urinary.
Case 10. Basic clinical and pathological data 49-year-old male Prostatic symptomatology Increased level of PSA (up to 6 ng/ml) Prostate 35 g 4x 4 x 3.
Advanced squamous cell carcinoma of the bladder, What is next? Saleh A. Binsaleh.
Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors) pathology, prognosis, and proposed classification McKenney,
Epidemiology 242: Pathology Basis of Caner Jian-Yu Rao, MD Professor of Pathology and Epidemiology Fall, 2009.
OVARY 2 Neoplasms of the Ovary
Ji Young Lee, MD, PhD, David Marchetti, MD, M Steven Piver, MD Department of Obstetrics and Gynecology Sisters of Charity Hospital, Buffalo, NY The Clinical.
Pathology of Kidney and the Urinary tract Dr. Amar C. Al-Rikabi Dr. Hala Kasouf Kfouri.
Dr. Abdelaty Shawky Dr. Gehan Mohamed
Ovary.
Urinary tract pathology-2. Renal Cell Carcinoma RCC account for 2% to 3% of all cancers in adults and are classified into three major types: Clear cell.
BLADDER Dr Frances McCormick Derriford Hospital.
6- RENAL CARCINOMA. Renal cell carcinoma occupying the lower renal pole Cross-section of kidney shows a well circumscribed yellowish tumor mass occupying.
RENAL PATHOLOGY SLIDE PRESENTATION By Dr.ASMAA NAJIM.
IOANNIS PILPILIDIS, MD, FEBGH DEPT of GASTROENTEROLOGY - ONCOLOGY “THEAGENEIO” ANTICANCER HOSPITAL of THESSALONIKI Athens, GALLBLADDER CARCINOMA.
Santa Monica 2006 IGCS - Interactive Session
Conservative Management of Borderline Ovarian Tumor Prof. Dr. Fuat Demirkıran I.U Cerrahpaşa School of Medicine. Department of OB&GYN Division Of Gynocol.
BLADDER CANCER 1.What proportion of deaths from bladder cancer could be improved if we could do a cystectomy earlier in the right people? 2.Do we allow.
LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:
Pathology of Kidney and the Urinary tract Dr. Amar C. Al-Rikabi Dr. Hala Kassouf Kfoury.
Notes by Dr Sanjay A Pai. Neoplasm An abnormal proliferation of cells, resulting in a mass called a neoplasm.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
T-cell/histiocyte-rich large B cell lymphoma Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital.
Tumors Dr. N. Salmo. Adrenal cortical tumor. Describe it grossly. Benign or Malignant??
Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age.
Leiomyosarcoma of the Vulva Bapir M, Hoh J & Al-Inizi S
Neoplasms of the bladder
PATHOLOGY OF THE URINARY OUTFLOW TRACT, MALE AND FEMALE GENITAL TRACT
Urinary Tract System Bladder Cancer.
Male Genital Tract 1, Case 4 62-year-old man presents with gross hematuria.
1 Tumors of Urinary Tract. 2 Urinary Tract Neoplasm KidneyRenal Cell Carcinoma [ adult], Transitional cell carcinoma [ adult], Wilms Tumor [children]
TUMORS OF THE KIDNEY AND URINARY BLADDER HALA KFOURY,MD.
Dr. Saadeh Jaber OBGYN consultant Epidemiology Second most common gynecological cancer. >35, median 70 It accounts for deaths more than cancer of.
Analysis of tumor-initiating cells in engrafted patient-derived human bladder carcinomas may direct precise cancer therapy Onyi Balogun 1†, Jukes Namm.
1 Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor Dep. of.
By Dr. Abdelaty Shawky Assistant professor of pathology
 T1 tumors at high risk of progression (high grade, multifocality, CIS, and tumor size, )  In all T1 patients failing intravesical therapy  muscle-invasive.
Ovarian Tumors Epidemiology - Ranks below only carcinoma of the cervix and the endometrium. -Ovarian cancer accounts for 6% of all cancers in the female.
NEOPLASIA DELLA TIROIDE: INTRODUZIONE ANATOMO-PATOLOGICA ALL’ARGOMENTO
TUMORS OF THE KIDNEY AND URINARY BLADDER
What is your clinical impression? What are the differential diagnosis?
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
Clear cell carcinoma of the ovary
An otherwise healthy 76 year-old man with h/o prostate cancer and renal cell carcinoma (s/p TURP and nephrectomy) was seen as part of his routine follow-up.
Urothelial tumors Tumors in the collecting system above the bladder are relatively uncommon. These tumors are classified into : 1 benign papilloma. 2-papillary.
Urine cytology (washed) KCP 802 Urine cytology (washed) 이대목동병원 박상희.
KCP 810 울산대학교 서울아산병원 병리과 전공의 송인혜. 환자 병력 40 세 / 여자 17 년 전 오른쪽 이하선 종양으로 부분절제 8 년 전 전절제, 방사선 치료 이후 재발 및 재수술 반복 경부 MRI 및 PET: 오른쪽 빗장위림프절 전이 의심 림프절 세포흡인검사.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
CASE PRESENTATION Clinical history 66 year old male Caucasian No prior history of malignancy Gross hematuria Urine cytology Positive.
LYMPHADENECTOMY IN UROTHELIAL CARCINOMA IN THE RENAL PELVIS AND URETER
Follicular variant of papillary thyroid carcinoma
Multiple primary malignant tumors M P M T
Seromucinous Tumor of the Ovary
Medical education in pathology
TUMORS OF THE KIDNEY AND URINARY BLADDER
استفاده از سیتوکراتین های 8 و 18 برای تشخیص زودرس سرطان مثانه
عنوان: بررسي فراواني انواع كانسرهاي تيروئيد از نظر زير گروه هيستوپاتولوژيك، توزيع سني، جنسي و محل آناتوميك آن در انستيتو كانسر و امام در طي سالهاي 1381.
Nomograms for Bladder Cancer
Benign Tumors of the Bladder
Clinicopathological and dermoscopic features of angio-eccrine hyperplasia in clear cell acanthoma  Giovanni Paolino, MD, Pietro Donati, MD, Angela Ferrari,
Role of cytokeratins in the diagnosis and prognosis of the bladder cancer Giorgi Adeishvili MD Multiprofile clinic Consilium Medulla.
Case 7.
Urinary bladder cancer
Case 3.
Combined data from RISC (n=3,024) and San Raffaele dataset (n=1,067)
Sensitivity and specificity plots of human epididymis protein 4 (HE4) (A and B, respectively) and carbohydrate antigen 125 (CA-125) (C and D, respectively)
A representative case of coexisting granulomatous inflammation (black arrowheads) and squamous cell carcinoma (white arrows) in a lobectomy specimen in.
Presentation transcript:

Case 6

Basic clinical data Archive case of I. Alvarado-Cabrero (Centro Medico, Mexico City) Archive case of I. Alvarado-Cabrero (Centro Medico, Mexico City) Hispanic male, 65 years Hispanic male, 65 years Tumor of the urinary bladder Tumor of the urinary bladder TRUS with subsequent cystectomy TRUS with subsequent cystectomy

Your opinion, diagnosis?

Scorpio Euscorpius spec

Micropapillary urothelial carcinoma cca 95 cases were published cca 95 cases were published Amin et al:Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 18, 1994, Amin et al:Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 18, 1994, WHO 2004-variant of TCC WHO 2004-variant of TCC

Basic clinico-pathologic features of micropapillary transitional cell carcinoma Main age: 66 years Main age: 66 years Male prevalence Male prevalence Vascular invasion is usually present in time of diagnosis Vascular invasion is usually present in time of diagnosis Usually high-grade tumors Usually high-grade tumors EMA/CK 7 usually positive EMA/CK 7 usually positive High stage in time of diagnosis, very bad prognosis (up to 12 months after establishing of the diagnosis) High stage in time of diagnosis, very bad prognosis (up to 12 months after establishing of the diagnosis)

Differential diagnostics High-grade „classic“ TCC High-grade „classic“ TCC Inverted papilloma Inverted papilloma „Nested“ variant of TCC „Nested“ variant of TCC

Micropapilary ca vs. inverted papilloma

Micropapillary ca-variants

Micropapilary ca vs. inverted papilloma